Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.92
2.19
NAV
₹46.10
₹44.45
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹3142.36 Cr
₹6668.95 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
8.85%
5.68%
3 Year
21.95%
26.25%
5 Year
14.24%
15.27%
Equity
96.75%
96.76%
Cash
3.25%
3.24%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.84% |
Ipca Laboratories Ltd. | 8.26% |
Cipla Ltd. | 7.56% |
Globus Medical Inc | 7.35% |
Laurus Labs Ltd. | 6.42% |
Illumina Inc. (USA) | 6.16% |
Sai Life Sciences Ltd. | 6.10% |
Gland Pharma Ltd. | 5.13% |
Cohance Lifesciences Ltd. | 4.83% |
Apollo Hospitals Enterprise Ltd. | 4.73% |
Sun Pharmaceutical Industries Ltd. | 11.76% |
Cipla Ltd. | 8.15% |
Mankind Pharma Ltd. | 7.58% |
Divi's Laboratories Ltd. | 6.06% |
Dr. Reddy's Laboratories Ltd. | 5.94% |
Biocon Ltd. | 5.81% |
Cohance Lifesciences Ltd. | 4.44% |
Lupin Ltd. | 3.80% |
Medplus Health Services Ltd. | 3.37% |
Alkem Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018
